Earnings Anticipation: Cardinal Health (CAH) is generating significant buzz on X as the company approaches its Q1 2026 earnings release, scheduled for October 30th. Investors are keenly focused on the expected earnings per share of $2.22 and revenue projections of over $59 billion. The discussion reflects a mix of curiosity and high expectations for the healthcare giant’s performance.
Stock Performance Buzz: Recent posts on X highlight Cardinal Health’s strong market performance, with some noting its impressive annualized return of 27.8% over the past five years. There’s chatter about the stock’s current price of around $161.89, with users intrigued by its consistent upward trajectory. This has sparked debates on whether the momentum will hold post-earnings.
Note: This discussion summary was generated from an AI condensation of post data.
Cardinal Health Insider Trading Activity
Cardinal Health insiders have traded $CAH stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.
Here’s a breakdown of recent trading of $CAH stock by insiders over the last 6 months:
- JASON M. HOLLAR (Chief Executive Officer) has made 0 purchases and 5 sales selling 143,606 shares for an estimated $21,424,215.
- AARON E ALT (Chief Financial Officer) has made 0 purchases and 2 sales selling 48,243 shares for an estimated $7,177,389.
- STEPHEN M MASON (CEO, GMPD Segment) has made 0 purchases and 3 sales selling 41,575 shares for an estimated $6,187,063.
- JESSICA L MAYER (Chief Legal/Compliance Officer) has made 0 purchases and 3 sales selling 38,078 shares for an estimated $5,666,832.
- OLA M SNOW (Chief Human Resources Officer) has made 0 purchases and 2 sales selling 28,151 shares for an estimated $4,192,916.
- DEBORAH WEITZMAN (CEO, PSS Segment) sold 21,367 shares for an estimated $3,216,374
- MICHELLE D. GREENE (Chief Information Officer) has made 0 purchases and 2 sales selling 13,500 shares for an estimated $2,009,043.
- MARY C. SCHERER (Chief Accounting Officer) sold 6,766 shares for an estimated $1,009,825
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Cardinal Health Congressional Stock Trading
Members of Congress have traded $CAH stock 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CAH stock by members of Congress over the last 6 months:
- REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 3 times. They made 3 purchases worth up to $45,000 on 10/24, 05/14, 05/05 and 0 sales.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Cardinal Health Hedge Fund Activity
We have seen 577 institutional investors add shares of Cardinal Health stock to their portfolio, and 534 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 2,271,634 shares (+56.7%) to their portfolio in Q2 2025, for an estimated $381,634,512
- CITADEL ADVISORS LLC removed 1,798,782 shares (-63.1%) from their portfolio in Q2 2025, for an estimated $302,195,376
- JPMORGAN CHASE & CO removed 1,653,607 shares (-39.6%) from their portfolio in Q2 2025, for an estimated $277,805,976
- NORGES BANK added 1,392,384 shares (+66.7%) to their portfolio in Q2 2025, for an estimated $233,920,512
- BLACKROCK, INC. removed 1,276,568 shares (-4.0%) from their portfolio in Q2 2025, for an estimated $214,463,424
- AMUNDI removed 1,183,078 shares (-62.2%) from their portfolio in Q2 2025, for an estimated $198,757,104
- LSV ASSET MANAGEMENT removed 849,442 shares (-46.4%) from their portfolio in Q2 2025, for an estimated $142,706,256
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Cardinal Health Government Contracts
We have seen $267,478,733 of award payments to $CAH over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- EXPRESS REPORT: MEDICAL SURGICAL PRIME VENDOR EXPENDITURES FOR THE MONTH OF OCTOBER 2024: $17,153,303
- EXPRESS REPORT: MEDICAL SURGICAL PRIME VENDOR EXPENDITURES FOR THE MONTH OF NOVEMBER 2024: $14,633,711
- EXPRESS REPORT: MEDICAL SURGICAL PRIME VENDOR EXPENDITURES FOR THE MONTH OF DECEMBER 2024: $11,666,188
- EXPRESS REPORT: MEDICAL SURGICAL PRIME VENDOR EXPENDITURES FOR THE MONTH OF APRIL 2025.: $10,194,510
- EXPRESS REPORT: MEDICAL SURGICAL PRIME VENDOR EXPENDITURES FOR THE MONTH OF JANUARY 2025: $9,899,536
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
Cardinal Health Analyst Ratings
Wall Street analysts have issued reports on $CAH in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Leerink Partners issued a "Outperform" rating on 08/12/2025
- Morgan Stanley issued a "Overweight" rating on 07/16/2025
- Evercore ISI Group issued a "Outperform" rating on 06/12/2025
- B of A Securities issued a "Buy" rating on 06/10/2025
- Wells Fargo issued a "Overweight" rating on 06/03/2025
To track analyst ratings and price targets for Cardinal Health, check out Quiver Quantitative's $CAH forecast page.
Cardinal Health Price Targets
Multiple analysts have issued price targets for $CAH recently. We have seen 7 analysts offer price targets for $CAH in the last 6 months, with a median target of $186.0.
Here are some recent targets:
- Stephen Baxter from Wells Fargo set a target price of $185.0 on 08/13/2025
- Elizabeth Anderson from Evercore ISI Group set a target price of $190.0 on 08/13/2025
- Eric Coldwell from Baird set a target price of $203.0 on 08/13/2025
- Michael Cherny from Leerink Partners set a target price of $186.0 on 08/12/2025
- Erin Wright from Morgan Stanley set a target price of $190.0 on 07/16/2025
- Daniel Grosslight from Citigroup set a target price of $170.0 on 06/13/2025
- Michael Cherny from B of A Securities set a target price of $170.0 on 06/10/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
